5-溴-2-(1H-咪唑-1-基)嘧啶 | 883230-68-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 中文名称: 5-溴-2-(1H-咪唑-1-基)嘧啶
• 英文名称: 5-bromo-2-(1H-imidazol-1-yl)pyrimidine
• 英文别名: 5-bromo-2-imidazol-1-ylpyrimidine
• CAS: 883230-68-0
• 化学式: C₇H₅BrN₄
• 分子量: 225.047
• InChiKey: SCDMEQDXMQROEY-UHFFFAOYSA-N

物化性质

• 熔点：
  160 °C (approx, decomp)
• 沸点：
  426.2±37.0 °C(Predicted)
• 密度：
  1.79±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  43.6
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 危险性防范说明：
  P264,P280,P302+P352,P337+P313,P305+P351+P338,P362+P364,P332+P313
• 危险性描述：
  H315,H319
• 储存条件：
  存放在2至8°C的环境中，并确保干燥。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 5-Bromo-2-(1h-imidazol-1-yl)pyrimidine
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 5-Bromo-2-(1h-imidazol-1-yl)pyrimidine
CAS number: 883230-68-0

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C7H5BrN4
Molecular weight: 225.0

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  吡唑 、 5-溴-2-(1H-咪唑-1-基)嘧啶 在 caesium carbonate 、 copper(II) nitrate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 24.0h， 以53%的产率得到5-溴-2-吡唑-1-基-嘧啶
  参考文献：
  名称：

  铜和嘧啶核周围的N-杂环取代基的铜催化C–N键交换

  摘要：

  S. Tao和E. Ji的贡献相等。 抽象的 描述了使用C–N键交换反应的铜催化转移N-杂芳基化策略。该反应可容纳范围广泛的带有卤素原子的吡啶和嘧啶环，它们对于随后的转化具有广泛的用途。该方法提供了直接且操作简单的方法，用于通过交换N杂环取代基来修饰复杂分子。 描述了使用C–N键交换反应的铜催化转移N-杂芳基化策略。该反应可容纳范围广泛的带有卤素原子的吡啶和嘧啶环，它们对于随后的转化具有广泛的用途。该方法提供了直接且操作简单的方法，用于通过交换N杂环取代基来修饰复杂分子。

  DOI：

  10.1055/s-0036-1590893
• 作为产物：
  描述：

  咪唑 、 5-溴-2-氟嘧啶 在 potassium carbonate 作用下， 以 二甲基亚砜 为溶剂， 反应 24.0h， 以95%的产率得到5-溴-2-(1H-咪唑-1-基)嘧啶
  参考文献：
  名称：

  铜和嘧啶核周围的N-杂环取代基的铜催化C–N键交换

  摘要：

  S. Tao和E. Ji的贡献相等。 抽象的 描述了使用C–N键交换反应的铜催化转移N-杂芳基化策略。该反应可容纳范围广泛的带有卤素原子的吡啶和嘧啶环，它们对于随后的转化具有广泛的用途。该方法提供了直接且操作简单的方法，用于通过交换N杂环取代基来修饰复杂分子。 描述了使用C–N键交换反应的铜催化转移N-杂芳基化策略。该反应可容纳范围广泛的带有卤素原子的吡啶和嘧啶环，它们对于随后的转化具有广泛的用途。该方法提供了直接且操作简单的方法，用于通过交换N杂环取代基来修饰复杂分子。

  DOI：

  10.1055/s-0036-1590893

文献信息

• [EN] OXAZOLIDINONE DERIVATIVES AS ANTIMICROBIALS<br/>[FR] DERIVES D'OXAZOLIDINONE UTILISES COMME AGENTS ANTIMICROBIENS
  申请人：RANBAXY LAB LTD

  公开号：WO2006038100A1

  公开（公告）日：2006-04-13

  The present invention relates to certain substituted phenyl oxazolidinones and to processes for the synthesis of the same. This invention also relates to pharmaceutical compositions containing the compounds of the present invention as antimicrobials. The compounds are useful antimicrobial agents, effective against a number of human and veterinary pathogens, including gram-positive aerobic bacteria, for example, multiple-resistant staphylococci, streptococci and enterococci as well as anaerobic organisms, for example, Bacterioides spp. and Clostridia spp. species, and acid fast organisms, for example, Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium spp.

  本发明涉及某些取代苯基噁唑烷酮以及其合成方法。本发明还涉及含有本发明化合物作为抗微生物药物的药物组合物。这些化合物是有用的抗微生物剂，对多种人类和兽医病原体有效，包括革兰氏阳性厌氧细菌，例如多重耐药葡萄球菌、链球菌和肠球菌，以及厌氧生物，例如Bacterioides属和Clostridia属物种，以及耐酸生物，例如结核分枝杆菌、埃维分枝杆菌和分枝杆菌属。
• Metal-free site-selective C–N bond-forming reaction of polyhalogenated pyridines and pyrimidines
  作者：Lei Wang、Ning Liu、Bin Dai

  DOI：10.1039/c5ra18653f

  日期：——

  of the pyridine ring to generate monosubstituted halogenated pyridines with high selectivities. Different halogen atoms at various positions were produced by the pyridine ring that performed well under mild conditions. Halogenated pyrimidines underwent highly selective coupling at the chloride group with a wide range of amines having broad substrate applicability and moderate to good yields. The selectivity

  本文提出了一种多金属的方法，用于多位卤代吡啶和嘧啶的高位点选择性C–N键形成反应。当从吡啶环变为嘧啶环时，优选的偶联位点可从带有N-杂环的氟基团调节至氯基团。各种各样的卤代吡啶优先与吡啶环氟原子上的胺反应，生成具有高选择性的单取代卤代吡啶。吡啶环在不同位置产生了不同的卤素原子，这些吡啶环在温和的条件下表现良好。卤代嘧啶在氯化物基团上与多种胺进行高度选择性的偶联，这些胺具有广泛的底物适用性并且产率中等至良好。氮环的邻位。该反应容纳了广泛的卤代基团。因此，产生了大量的氯，溴，碘和氟吡啶，它们对于有机合成具有广泛的用途。
• Rapid access to diverse, trifluoromethyl-substituted alkenes using complementary strategies
  作者：James P. Phelan、Rebecca J. Wiles、Simon B. Lang、Christopher B. Kelly、Gary A. Molander

  DOI：10.1039/c7sc05420c

  日期：——

  alkenes, cross-coupling or related functionalization processes at distal electrophilic sites can be executed without inducing Peterson elimination. Subsequent Lewis acidic activation affords functionalized α-trifluoromethyl alkenes. Likewise, the development of a novel α-trifluoromethylvinyl trifluoroborate reagent complements this approach and allows a one-step cross-coupling of (hetero)aryl halides to

  描述了两种简单的方法来轻松组装复杂的α-三氟甲基烯烃。使用α-三氟甲基-β-甲硅烷基醇作为掩蔽的三氟甲基烯烃，可以在不引起彼得森消除的情况下在远端亲电部位进行交叉偶联或相关的官能化过程。随后的路易斯酸性活化得到官能化的α-三氟甲基烯烃。同样，新型α-三氟甲基乙烯基三氟硼酸酯试剂的开发对这种方法进行了补充，并且允许（杂）芳基卤化物的一步式交叉偶联来获得各种各样的复杂α-三氟甲基烯烃。
• A focused fragment library targeting the antibiotic resistance enzyme - Oxacillinase-48: Synthesis, structural evaluation and inhibitor design
  作者：Sundus Akhter、Bjarte Aarmo Lund、Aya Ismael、Manuel Langer、Johan Isaksson、Tony Christopeit、Hanna-Kirsti S. Leiros、Annette Bayer

  DOI：10.1016/j.ejmech.2017.12.085

  日期：2018.2

  β-lactamase inhibitors and today several β-lactamase inhibitors e.g. avibactam, are approved in the clinic. Our focus is the oxacillinase-48 (OXA-48), an enzyme reported to spread rapidly across the world and commonly identified in Escherichia coli and Klebsiella pneumoniae. To guide inhibitor design, we used diversely substituted 3-aryl and 3-heteroaryl benzoic acids to probe the active site of OXA-48

  当在医学界中治疗细菌感染时，β-内酰胺抗生素至关重要。然而，目前它们的效用受到β-内酰胺抗性的出现和扩散的威胁。对β-内酰胺抗生素最普遍的耐药机制是β-内酰胺酶的表达。克服由β-内酰胺酶引起的抗性的一种方法是开发β-内酰胺酶抑制剂，如今临床上已经批准了几种β-内酰胺酶抑制剂，例如阿维巴坦。我们的研究重点是oxacillinase-48（OXA-48），据报道该酶在世界范围内迅速传播，通常在大肠杆菌和肺炎克雷伯菌中得到鉴定。为了指导抑制剂的设计，我们使用了不同取代的3-芳基和3-杂芳基苯甲酸来探测OXA-48的活性位点，以进行有用的酶-抑制剂相互作用。在本研究中，合成了包含49个3-取代的苯甲酸衍生物的聚焦片段文库，并对其进行了生化表征。基于从33片段的酶复合物晶体学数据，片段可以被归类为R 1或R 2个可以通过总体结合构象相对于粘合剂到R的结合1和R 2亚胺培南的侧基。此外，发现了对未来抑
• Sequential Metal-CatalyzedN-Heteroarylation and C–C Cross-Coupling Reactions: An Expedient Route to Tris(hetero)aryl Systems
  作者：Jamie S. Siddle、Andrei S. Batsanov、Martin R. Bryce

  DOI：10.1002/ejoc.200800018

  日期：2008.6

  1-methylbenzimidazolone, imidazole and pyrrole. The products of these reactions then undergo palladium-catalyzed C–C cross-couplings with aryl or heteroarylboronic acids under Suzuki–Miyaura conditions to provide a rapid entry, from readily-available reagents, into tris(hetero)aryl scaffolds comprising two or three N-heterocyclic rings. The sequential N–C and C–C couplings can be performed in a one-pot process (two

  本文描述了铜催化的苯并咪唑、1-甲基苯并咪唑酮、咪唑和吡咯的 N-C 杂芳基化反应。然后，这些反应的产物在 Suzuki-Miyaura 条件下与芳基或杂芳基硼酸进行钯催化的 C-C 交叉偶联，以提供从容易获得的试剂快速进入包含两个或三个 N 的三（杂）芳基支架-杂环。连续的 N-C 和 C-C 偶联可以在一锅法中进行（给出了两个例子：>50% 的总产率）。(© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2008)